Year : 2011 | Volume
: 2 | Issue : 3 | Page : 135-
Journal of advanced pharmaceutical technology and research
Editor, Journal of Advanced Pharmaceutical Technology and Research (JAPTR), Society of Pharmaceutical Education and Research, 22-C, Jawahar Colony, Gwalior - 474 001, M.P, India
Editor, Journal of Advanced Pharmaceutical Technology and Research (JAPTR), Society of Pharmaceutical Education and Research, 22-C, Jawahar Colony, Gwalior - 474 001, M.P
|How to cite this article:|
Nagaich U. Journal of advanced pharmaceutical technology and research.J Adv Pharm Technol Res 2011;2:135-135
|How to cite this URL:|
Nagaich U. Journal of advanced pharmaceutical technology and research. J Adv Pharm Technol Res [serial online] 2011 [cited 2020 Jul 11 ];2:135-135
Available from: http://www.japtr.org/text.asp?2011/2/3/135/85522
In the continuity of the publication of this journal, I welcome you to this third issue of the second volume for 2011. It gives me immense of pleasure to let you know that this issue consists of some research-oriented and well-informed articles such as: Transferosomes, creation of small drop and cost-effectiveness of ophthalmic drops, evaluation of several microcrystalline celluloses obtained from agricultural by-products, and delayed-release multiparticulates.
Our journal has recently included one of the most prestigious and reputed bibliographic indexing agencies; Scimago Journal Ranking (SJR) and Scopus. The efforts of our reviewer's have seen the light of the day with the inclusion of our journal in these agencies. Journal of Advanced Pharmaceutical Technology and Research committed to elevate the innovative and inventive nature of the journal for two major aspects: First, to maintain the quality contents and second, to make them for intensive and extensive readings and to make it more and more research oriented for serving in the field of pharmaceutical sciences. In order to maintain the quality of the research articles published in the journal, we are confident to get indexed in PubMed and PubMed Central soon.
It has been and will be our sole motive to focus on the content for including ever expanding newness so far as the quality of the peer-reviewing contents are concerned. For this purpose, we are in association with various learned scientists and academicians. The suggestions given by the reviewers helped us to select the quality research work for publication in the journal.
With the release of this journal in 2010, the response and appreciation we receiving regarding the inclusion of the articles from various scientists, scholars, and academicians have motivated me to continue with this effort and have encouraged me to carry on the streams of pharmaceutical knowledge. I would like to thank our active reviewers to be associated with us and for their critical comments on the manuscript assigned to them for the purpose of reviewing. With their thought provoking and timely suggestions our journal is being indexed in most prestigious indexing agencies in such a short span of time.
We have received so many query mails from the authors asking about the tentative time required to publish the article online from the date of their submission. I would like to clarify all the research scholars and academicians that for publishing one issue it will take around 3-4 months and sometimes up to more than 6 months for completing the peer-review process and refining the quality of the articles received in their original form. Author should think of the quality-based publication instead of counting the number of publications.
With regards and appeal is from scholars, authors is made for contributing such papers which show their original approach, analytical methods and scientific temperament for indexing yet again in many international bibliographic agencies.
With thanks and regards,